Sumitomo Mitsui DS Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7M Buy
190,060
+9,948
+6% +$888K 0.14% 132
2026
Q1
$12.9M Buy
180,112
+3,744
+2% +$288K 0.1% 167
2025
Q4
$14M Buy
176,368
+1,381
+0.8% +$109K 0.11% 158
2025
Q3
$13.2M Buy
174,987
+5,860
+3% +$402K 0.11% 169
2025
Q2
$11.7M Buy
169,127
+1,739
+1% +$114K 0.11% 167
2025
Q1
$11.3M Buy
167,388
+10,039
+6% +$601K 0.12% 156
2024
Q4
$7.06M Sell
157,349
-11,958
-7% -$671K 0.07% 218
2024
Q3
$10.6M Buy
169,307
+24,472
+17% +$1.43M 0.11% 159
2024
Q2
$8.55M Buy
144,835
+24
+0% +$1.5K 0.1% 167
2024
Q1
$11.6M Buy
144,811
+8,845
+7% +$676K 0.14% 135
2023
Q4
$10.7M Sell
135,966
-245
-0.2% -$17.4K 0.14% 158
2023
Q3
$9.51M Buy
136,211
+4,817
+4% +$341K 0.15% 130
2023
Q2
$9.08M Buy
131,394
+22,037
+20% +$1.57M 0.14% 136
2023
Q1
$8.13M Buy
109,357
+7,035
+7% +$590K 0.15% 127
2022
Q4
$9.54M Buy
102,322
+4,793
+5% +$462K 0.19% 102
2022
Q3
$9.3M Buy
97,529
+7,298
+8% +$722K 0.21% 89
2022
Q2
$8.36M Buy
90,231
+4,968
+6% +$485K 0.2% 94
2022
Q1
$8.63M Sell
85,263
-2,567
-3% -$270K 0.18% 105
2021
Q4
$9.06M Buy
87,830
+2,660
+3% +$246K 0.19% 104
2021
Q3
$7.23M Sell
85,170
-673
-0.8% -$56.4K 0.17% 118
2021
Q2
$7.16M Buy
85,843
+2,081
+2% +$170K 0.17% 122
2021
Q1
$6.3M Buy
83,762
+256
+0.3% +$18.6K 0.17% 130
2020
Q4
$5.7M Sell
83,506
-2,090
-2% -$136K 0.16% 122
2020
Q3
$5M Buy
85,596
+6,509
+8% +$405K 0.16% 116
2020
Q2
$5.14M Buy
79,087
+137
+0.2% +$8.63K 0.18% 110
2020
Q1
$4.68M Sell
78,950
-2,764
-3% -$185K 0.19% 106
2019
Q4
$6.07M Buy
81,714
+1,229
+2% +$86.3K 0.21% 104
2019
Q3
$5.08M Buy
80,485
+7,578
+10% +$449K 0.19% 116
2019
Q2
$3.97M Sell
72,907
-22,012
-23% -$1.19M 0.16% 133
2019
Q1
$5.12M Buy
94,919
+9,014
+10% +$556K 0.08% 196
2018
Q4
$5.63M Buy
85,905
+15,960
+23% +$1.19M 0.1% 162
2018
Q3
$5.51M Sell
69,945
-957
-1% -$68.4K 0.08% 181
2018
Q2
$4.56M Buy
70,902
+1,096
+2% +$72.2K 0.07% 203
2018
Q1
$4.34M Sell
69,806
-3,616
-5% -$259K 0.06% 226
2017
Q4
$5.32M Sell
73,422
-4,247
-5% -$309K 0.08% 199
2017
Q3
$6.32M Sell
77,669
-3,812
-5% -$302K 0.1% 181
2017
Q2
$6.55M Sell
81,481
-6,697
-8% -$529K 0.11% 180
2017
Q1
$6.92M Buy
88,178
+8,131
+10% +$649K 0.12% 173
2016
Q4
$6.32M Sell
80,047
-3,122
-4% -$253K 0.12% 172
2016
Q3
$7.4M Sell
83,169
-1,287
-2% -$121K 0.16% 160
2016
Q2
$8.09M Buy
84,456
+927
+1% +$92.4K 0.25% 115
2016
Q1
$8.66M Buy
83,529
+2,387
+3% +$232K 0.27% 111
2015
Q4
$7.93M Sell
81,142
-4,074
-5% -$399K 0.27% 114
2015
Q3
$8.22M Sell
85,216
-198
-0.2% -$20.8K 0.28% 112
2015
Q2
$8.96M Sell
85,414
-4,806
-5% -$491K 0.28% 109
2015
Q1
$9.31M Sell
90,220
-8,398
-9% -$850K 0.28% 105
2014
Q4
$9.5M Sell
98,618
-9,781
-9% -$862K 0.29% 97
2014
Q3
$8.63M Sell
108,399
-8,954
-8% -$706K 0.26% 104
2014
Q2
$8.84M Sell
117,353
-8,295
-7% -$627K 0.25% 110
2014
Q1
$9.41M Sell
125,648
-12,253
-9% -$865K 0.28% 90
2013
Q4
$9.87M Sell
137,901
-10,831
-7% -$696K 0.28% 88
2013
Q3
$8.44M Sell
148,732
-7,867
-5% -$469K 0.24% 97
2013
Q2
$8.95M Buy
+156,599
New +$9.07M 0.25% 91

Other funds holding CVS

Sumitomo Mitsui DS Asset Management's CVS Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its CVS Health (CVS) stake by 5.5% in Q2 2026, buying an estimated $888K and bringing the position to 190,060 shares worth $19.7M. The position accounts for 0.14% of the portfolio, ranked #132.

Sumitomo Mitsui DS Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 190,060 shares of CVS Health worth $19.7M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 9,948 CVS Health shares in Q2 2026, an estimated $888K.
  • CVS Health made up 0.14% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #132 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.